Navalign LLC
MRK icon

Navalign LLC’s Merck MRK Stock Holding History

Navalign LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.24M Sell
15,391
-749
-5% -$103K 0.51% 31
2026
Q2 		$2.07M Buy
16,140
+215
+1% +$25.2K 0.48% 34
2026
Q1 		$1.92M Buy
15,925
+219
+1% +$25.3K 0.48% 34
2025
Q4 		$1.65M Buy
15,706
+1,103
+8% +$104K 0.41% 44
2025
Q3 		$1.23M Buy
14,603
+408
+3% +$33.6K 0.32% 52
2025
Q2 		$1.12M Buy
14,195
+77
+0.5% +$6.12K 0.31% 55
2025
Q1 		$1.27M Buy
14,118
+516
+4% +$48.2K 0.36% 48
2024
Q4 		$1.35M Buy
13,602
+453
+3% +$46.7K 0.4% 43
2024
Q3 		$1.49M Buy
13,149
+227
+2% +$27K 0.44% 37
2024
Q2 		$1.6M Buy
12,922
+348
+3% +$44.8K 0.5% 33
2024
Q1 		$1.66M Sell
12,574
-272
-2% -$33.5K 0.55% 30
2023
Q4 		$1.4M Sell
12,846
-236
-2% -$24.5K 0.49% 38
2023
Q3 		$1.35M Buy
13,082
+505
+4% +$54.4K 0.51% 34
2023
Q2 		$1.45M Sell
12,577
-204
-2% -$23.2K 0.58% 29
2023
Q1 		$1.36M Sell
12,781
-818
-6% -$88.3K 0.57% 32
2022
Q4 		$1.51M Sell
13,599
-548
-4% -$56K 0.62% 30
2022
Q3 		$1.22M Sell
14,147
-109
-0.8% -$9.7K 0.55% 30
2022
Q2 		$1.3M Sell
14,256
-363
-2% -$32.2K 0.57% 31
2022
Q1 		$1.23M Buy
14,619
+305
+2% +$24K 0.52% 38
2021
Q4 		$1.1M Sell
14,314
-86
-0.6% -$6.85K 0.44% 46
2021
Q3 		$1.08M Buy
14,400
+1,287
+10% +$97.9K 0.46% 47
2021
Q2 		$1.02M Sell
13,113
-201
-2% -$15K 0.43% 50
2021
Q1 		$979K Buy
+13,314
New +$982K 0.43% 49

Other funds holding MRK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Navalign LLC's MRK Position: Q3 2026 in Review

Navalign LLC reduced its Merck (MRK) stake by 4.6% in Q3 2026, selling an estimated $103K and leaving 15,391 shares worth $2.24M. The position accounts for 0.51% of the portfolio, ranked #31.

Navalign LLC first reported a position in MRK in Q1 2021 and has held it in 23 quarters since. 2,771 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Navalign LLC held 15,391 shares of Merck worth $2.24M as of Q3 2026.
  • Navalign LLC sold 749 Merck shares in Q3 2026, an estimated $103K.
  • Merck made up 0.51% of Navalign LLC's portfolio in Q3 2026, its #31 holding.
  • Navalign LLC first reported a position in Merck in Q1 2021 and has held it in 23 quarters since.
  • 2,771 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Navalign LLC's 13F filing for Q3 2026, filed 9 Nov 2026.